Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
The India anti-obesity drugs market size reached USD 80 million in 2024 and will grow to USD 190 million by 2033, exhibiting a growth rate (CAGR) of 9.9% during 2025-2033, says IMARC, a market research group
Even with consistent use, weight loss on GLP-1 medications rarely follows a straight downward path
Models of GLP-1 RAs were most sensitive to the effects of GLP-1 RAs on all-cause mortality, with the ICERs varying from AU$72,318 to AU$172,072 per QALY in the total population and AU$58,588 to AU$142,317 in the secondary prevention population for the lower and upper bounds of the 95% CI of the HR for GLP-1 RAs
Individuals with pre-existing liver conditions should use caution because the liver plays a central role in metabolizing the lipotropic compounds
US$ 26.49
US$ 28.94
